The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2019
Filed:
Nov. 28, 2017
Applicant:
Aura Biosciences, Inc., Cambridge, MA (US);
Inventors:
Elisabet de los Pinos, Brookline, MA (US);
Rhonda C. Kines, Washington, DC (US);
Assignee:
Aura Biosciences, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 45/06 (2006.01); A61K 49/00 (2006.01); A61K 38/16 (2006.01); A61K 9/51 (2006.01); A61K 51/08 (2006.01); A61K 47/69 (2017.01); B82Y 5/00 (2011.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0056 (2013.01); A61K 9/16 (2013.01); A61K 9/5184 (2013.01); A61K 38/162 (2013.01); A61K 45/06 (2013.01); A61K 47/6901 (2017.08); A61K 47/6929 (2017.08); A61K 51/088 (2013.01); A61K 9/0019 (2013.01); B82Y 5/00 (2013.01);
Abstract
The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects.